Works matching DE "FULVESTRANT"

Results: 199
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial.

    Published in:
    Oncologist, 2023, v. 28, n. 1, p. 23, doi. 10.1093/oncolo/oyac205
    By:
    • Cosimo, Serena Di;
    • Pérez-García, José Manuel;
    • Bellet, Meritxell;
    • Dalenc, Florence;
    • Gil, Miguel J Gil;
    • Borrego, Manuel Ruiz;
    • Gavilá, Joaquín;
    • Sampayo-Cordero, Miguel;
    • Aguirre, Elena;
    • Schmid, Peter;
    • Marmé, Frederik;
    • Gligorov, Joseph;
    • Schneeweiss, Andreas;
    • Albanell, Joan;
    • Zamora, Pilar;
    • Wheatley, Duncan;
    • Dueñas, Eduardo Martínez-De;
    • Carañana, Vicente;
    • Amillano, Kepa;
    • Mina, Leonardo
    Publication type:
    Article
    10
    11
    12
    13

    Bireociclib plus fulvestrant for HR+/HER2- advanced female breast cancer progressed on or after endocrine therapy: phase 3 BRIGHT-2 study interim analysis.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-58647-z
    By:
    • Wang, Jiayu;
    • Zhang, Qingyuan;
    • Li, Huiping;
    • Tong, Zhongsheng;
    • Ouyang, Quchang;
    • Li, Huihui;
    • Teng, Yuee;
    • Wang, Biyun;
    • Sun, Tao;
    • Wang, Jingfen;
    • Li, Wei;
    • Niu, Zhaofeng;
    • Li, Hongsheng;
    • Gong, Chang;
    • Wang, Shu;
    • Wang, Xinshuai;
    • Wu, Xinhong;
    • Liu, Ning;
    • Yu, Guohua;
    • Liu, Fei
    Publication type:
    Article
    14

    Lerociclib plus fulvestrant in patients with HR+/HER2− locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-56096-2
    By:
    • Xu, Binghe;
    • Zhang, Qingyuan;
    • Luo, Yang;
    • Tong, Zhongsheng;
    • Sun, Tao;
    • Shan, Changping;
    • Liu, Xinlan;
    • Yao, Yumin;
    • Zhao, Bing;
    • Wang, Shusen;
    • Zeng, Xiaohua;
    • Hu, Changlu;
    • Yan, Xi;
    • Wang, Xiaojia;
    • Jia, Hongyan;
    • Chen, Zhendong;
    • Qiu, Fuming;
    • Wu, Xinhong;
    • Zhang, Deyong;
    • Li, Tong
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Somatic BRCA2 Mutation-Positive Concurrent Accessory Male Breast Cancer (BC) and Non-Small Cell Lung Cancer (NSCLC): Excellent Efficacy of Palbociclib, Fulvestrant and Leuprolide in Platinum-Exposed and Endocrine-Refractory BC Associated with Cyclin D1 and FGFR1 Amplification and of Carboplatin, Paclitaxel and Radiation in NSCLC

    Published in:
    Case Reports in Oncology, 2019, v. 12, n. 2, p. 494, doi. 10.1159/000501304
    By:
    • Cheng, Yu;
    • Li, Ningjing;
    • Eapen, Ann;
    • Parajuli, Ritesh;
    • Mehta, Rita
    Publication type:
    Article
    21
    22
    23
    24
    25

    Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.

    Published in:
    British Journal of Cancer, 2015, v. 113, n. 4, p. 585, doi. 10.1038/bjc.2015.247
    By:
    • Quenel-Tueux, Nathalie;
    • Debled, Marc;
    • Rudewicz, Justine;
    • MacGrogan, Gaetan;
    • Pulido, Marina;
    • Mauriac, Louis;
    • Dalenc, Florence;
    • Bachelot, Thomas;
    • Lortal, Barbara;
    • Breton-Callu, Christelle;
    • Madranges, Nicolas;
    • de Lara, Christine Tunon;
    • Fournier, Marion;
    • Bonnefoi, Hervé;
    • Soueidan, Hayssam;
    • Nikolski, Macha;
    • Gros, Audrey;
    • Daly, Catherine;
    • Wood, Henry;
    • Rabbitts, Pamela
    Publication type:
    Article
    26
    27
    28
    29

    EILEEN STUDY: A RETROSPECTIVE REAL-WORLD ANALYSIS OF RESPONSE RATES WITH RIBOCICLIB AND ENDOCRINE THERAPY IN POSTMENOPAUSAL HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE METASTATIC BREAST CANCER.

    Published in:
    2024
    By:
    • Karaçin, Cengiz;
    • Başaran, Gül;
    • Kaplan, Muhammet Ali;
    • Göksu, Sema Sezgin;
    • Gümüş, Mahmut;
    • Inal, Ali;
    • Aksoy, Sercan;
    • Geredeli, Çağlayan;
    • Küçükzeybek, Yüksel;
    • Erdem, Dilek;
    • Gökmen, Erhan;
    • Harputluoğlu, Hakan;
    • Çilingiroğlu, Merve;
    • Gülkaya, Hayriye;
    • Uysal, Rana;
    • Nahit Şendur, Mehmet Ali
    Publication type:
    Abstract
    30
    31
    32
    33
    34
    35
    36

    Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67126-2
    By:
    • Lorman-Carbó, Natàlia;
    • Martínez-Sáez, Olga;
    • Fernandez-Martinez, Aranzazu;
    • Galván, Patricia;
    • Chic, Nuria;
    • Garcia-Fructuoso, Isabel;
    • Rodríguez, Adela;
    • Gómez-Bravo, Raquel;
    • Schettini, Francesco;
    • Blasco, Paula;
    • Castillo, Oleguer;
    • González-Farré, Blanca;
    • Adamo, Barbara;
    • Vidal, Maria;
    • Muñoz, Montserrat;
    • Perou, Charles M.;
    • Malumbres, Marcos;
    • Gavilá, Joaquín;
    • Pascual, Tomás;
    • Prat, Aleix
    Publication type:
    Article
    37

    Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67126-2
    By:
    • Lorman-Carbó, Natàlia;
    • Martínez-Sáez, Olga;
    • Fernandez-Martinez, Aranzazu;
    • Galván, Patricia;
    • Chic, Nuria;
    • Garcia-Fructuoso, Isabel;
    • Rodríguez, Adela;
    • Gómez-Bravo, Raquel;
    • Schettini, Francesco;
    • Blasco, Paula;
    • Castillo, Oleguer;
    • González-Farré, Blanca;
    • Adamo, Barbara;
    • Vidal, Maria;
    • Muñoz, Montserrat;
    • Perou, Charles M.;
    • Malumbres, Marcos;
    • Gavilá, Joaquín;
    • Pascual, Tomás;
    • Prat, Aleix
    Publication type:
    Article
    38
    39
    40
    41
    42

    New insights into estrogenic regulation of O<sup>6</sup>-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O<sup>6</sup>-benzylguanine indicates fresh avenues for therapy.

    Published in:
    Journal of Biomedical Research, 2016, v. 30, n. 5, p. 393, doi. 10.7555/JBR.30.20160040
    By:
    • Paranjpe, Ameya;
    • Bailey, Nathan I.;
    • Yusuf, Mohd. A.;
    • Punganuru, Surendra R.;
    • Madala, Hanumantha Rao;
    • Basak, Debasish;
    • Mostofa, A. G. M.;
    • Srivenugopal, Kalkunte S.;
    • Konduri, Santhi;
    • Bobustuc, George C.;
    • Ali-Osman, Francis
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50